Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:2910-2917
Published online before print October 25, 2004, doi: 10.1161/01.CIR.0000147538.92263.3A
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/18/2910    most recent
01.CIR.0000147538.92263.3Av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afanasyeva, M.
Right arrow Articles by Rose, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Afanasyeva, M.
Right arrow Articles by Rose, N. R.
Related Collections
Right arrow Pericardial disease
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Growth factors/cytokines
Right arrow Heart failure - basic studies
Right arrow Myocardial cardiomyopathy disease

(Circulation. 2004;110:2910-2917.)
© 2004 American Heart Association, Inc.


Molecular Cardiology

Novel Model of Constrictive Pericarditis Associated With Autoimmune Heart Disease in Interferon-{gamma}–Knockout Mice

Marina Afanasyeva, MD, MPH, PhD*; Dimitrios Georgakopoulos, PhD*; DeLisa Fairweather, PhD; Patrizio Caturegli, MD; David A. Kass, MD; Noel R. Rose, MD, PhD

From the Department of Pathology (M.A., D.F., P.C., N.R.R.), Department of Medicine (D.G., D.A.K.), and W. Harry Feinstone Department of Molecular Microbiology and Immunology (N.R.R.), Johns Hopkins Medical Intitutions, Baltimore, Md.

Correspondence to Marina Afanasyeva, MD, MPH, PhD, or Dimitrios Georgakopoulos, PhD, University of Calgary, Cardiovascular Research Group, Faculty of Medicine, 3330 Hospital Dr NW, Health Sciences Centre, Room 1640, Calgary AB T2N 4N1, Alberta, Canada. E-mail afanasym{at}ucalgary.ca or dgeorgak@ucalgary.ca

Received June 9, 2004; revision received August 5, 2004; accepted August 11, 2004.

Background— Constrictive pericarditis represents a serious hemodynamic syndrome that may lead to heart failure. Studies of its pathophysiological mechanisms have been impeded by the lack of an animal model.

Methods and Results— Cardiac myosin–induced experimental autoimmune myocarditis in interferon (IFN)-{gamma}–knockout (KO) mice results in increased cardiac inflammation and development of severe grossly detectable pericarditis. Using in vivo pressure-volume studies, we found that the acute phase of experimental autoimmune myocarditis in IFN-{gamma}–KO mice was characterized by reduced left ventricular (LV) volumes compared with wild-type mice. The KO mice exhibited a classic restrictive/constrictive phenotype with decreased cardiac output, increased chamber stiffness, preserved ejection fraction, and impaired diastolic filling, characterized by reduced deceleration time and pressure tracings showing the square root sign similar to that observed in clinical cases of constrictive pericarditis. This phenotype was not associated with the severity of myocarditis but correlated with the presence of grossly detectable adhesive pericarditis present only in the KO group and characterized by increased pericardial inflammation and fibrosis. Comparison of IFN-{gamma}–KO and wild-type mice matched for the severity of myocardial disease further confirmed that pericarditis, and not myocarditis, was responsible for smaller LV volumes, reduced cardiac output, increased cardiac stiffness, and increased peak filling rate adjusted for end-diastolic volumes in KO mice.

Conclusions— Autoimmune heart disease in IFN-{gamma}–KO mice results in increased pericardial inflammation and fibrosis, leading to constrictive phenotype during the acute phase of disease. It represents a novel animal model of constrictive pericarditis.


Key Words: cardiac output • pressure–volume relation • hemodynamics • inflammation • myocarditis




This article has been cited by other articles:


Home page
BloodHome page
J. Morton, B. Coles, K. Wright, A. Gallimore, J. D. Morrow, E. S. Terry, P. B. Anning, B. P. Morgan, V. Dioszeghy, H. Kuhn, et al.
Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFN{gamma}-dependent iNOS expression in the vasculature of healthy mice
Blood, May 15, 2008; 111(10): 5187 - 5194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Cihakova, J. G. Barin, M. Afanasyeva, M. Kimura, D. Fairweather, M. Berg, M. V. Talor, G. C. Baldeviano, S. Frisancho, K. Gabrielson, et al.
Interleukin-13 Protects Against Experimental Autoimmune Myocarditis by Regulating Macrophage Differentiation
Am. J. Pathol., May 1, 2008; 172(5): 1195 - 1208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Fairweather, S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose
Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1beta, and Immune Complex Deposition in the Heart
J. Immunol., March 15, 2006; 176(6): 3516 - 3524.
[Abstract] [Full Text] [PDF]